检验医学 ›› 2021, Vol. 36 ›› Issue (1): 44-47.DOI: 10.3969/j.issn.1673-8640.2021.01.009

• 临床应用研究·论著 • 上一篇    下一篇

上海市COVID-19患者康复前后淋巴细胞绝对数分析

樊剑, 郭颖, 戚伟强, 郜梦露, 张腾飞, 朱召芹()   

  1. 上海市公共卫生临床中心,上海 201508
  • 收稿日期:2020-03-31 出版日期:2021-01-30 发布日期:2021-02-05
  • 作者简介:null

    作者简介:樊 剑,男,1986年生,主管技师,主要从事临床医学检验工作。

  • 基金资助:
    上海市科学技术委员会应急攻关项目(20411950502);上海市公共卫生临床中心院内专项课题(2020YJKY01);国家“十三五”科技部重大专项项目(2018ZX10714002-001-005)

Analysis on the absolute value of lymphocyte in COVID-19 patients before and after recovery in Shanghai

FAN Jian, GUO Ying, QI Weiqiang, HAO Menglu, ZHANG Tengfei, ZHU Zhaoqin()   

  1. Shanghai Public Health Clinical Center,Shanghai 201508,China
  • Received:2020-03-31 Online:2021-01-30 Published:2021-02-05

摘要:

目的 评估淋巴细胞绝对数(LYMPH#)检测在新型冠状病毒肺炎(COVID-19)患者临床预后判断中的价值。方法 选取123例严重急性呼吸综合征冠状病毒2(SARS-CoV-2)感染患者作为研究对象,其中轻型及普通型112例(轻型及普通型组),重型及危重型11例(重型及危重型组)。回顾性收集所有患者外周血LYMPH#的初诊检测结果、出院前检测结果和初次随访检测结果;收集所有患者的临床资料。结果 重症患者的年龄比轻症患者大。轻型及普通型组50.89%(57/112)的患者LYMPH#初诊检测结果低于正常值,重型及危重型组72.73%(8/11)的患者LYMPH#初诊检测结果低于正常值。轻型及普通型组和重型及危重型组LYMPH#初诊检测结果比较,无显著性差异(P=0.789)。轻型及普通型组和重型及危重型组之间LYMPH#恢复数值[(初次随访检测结果-初诊检测结果)/初次随访检测结果]和LYMPH#差值(初次随访检测结果-出院前检测结果)均有显著性差异(P=0.014和P=0.038)。结论 SARS-CoV-2感染患者的细胞免疫功能普遍低下,康复出院的重症患者免疫功能需要进行持续监测,LYMPH#可作为临床监测COVID-19患者免疫功能和评估预后的指标。

关键词: 新型冠状病毒肺炎, 淋巴细胞绝对数, 预后

Abstract:

Objective To evaluate the role of absolute lymphocyte count(LYMPH#)in predicting prognosis of corona virus disease 2019(COVID-19)patients. Methods A total of 123 COVID-19 patients were enrolled in this retrospective study. There were 112 mild cases and 11 severe cases. The LYMPH# in peripheral blood were collected at the initial hospitalization,before discharge,and at the initial follow-up. Clinical data of all the patients were also collected. Results Severe patients were older than mild patients. At the initial hospitalization,the LYMPH# of 50.89%(57/112)of mild group was lower than normal value,and the LYMPH# of 72.73%(8/11)of severe group was lower than referencevalue. There was no significant difference in the LYMPH# between mild group and severe group at the initial hospitalization(P=0.789). There was significant difference in the recovery LYMPH# [(initial follow-up results-first admission results)/initial follow-up results] between the two groups(P=0.014). There was the difference of LYMPH# between before discharge and the first follow-up(P=0.038). Conclusion The cellular immune function of COVID-19 patients is generally low,and needs continuous monitoring. LYMPH# can be used as an indicator to monitor the immune function and predict the prognosis of COVID-19 patients.

Key words: Corona virus disease 2019, Absolute lymphocyte count, Prognosis

中图分类号: